Company news

Cocrystal Pharma, Inc. news in 2019

Cocrystal Pharma, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Cocrystal Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 11, 2019

Cocrystal Pharma Presents Positive Data from U.S. Phase 2a Study of CC-31244 Demonstrating Ability to Identify Patients More Likely to Respond to Ultrashort Treatment of HCV

November 10, 2019

Cocrystal Pharma, Inc. prices $3,000,000 underwritten public offering

October 30, 2019

Cocrystal Pharma, Inc. announces proposed underwritten public offering of common stock

October 29, 2019

Cocrystal Pharma Announces New Data on CC-31244 and Abstract Acceptance for Poster Presentation at the AASLD 2019 Liver Meeting

October 29, 2019

Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus and Related Viruses

September 30, 2019

Decks in 2019